Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126159341 | 12615934 | 1 | I | 201607 | 20160727 | 20160802 | 20160802 | EXP | US-INCYTE CORPORATION-2016IN004691 | INCYTE | 74.14 | YR | M | Y | 0.00000 | 20160802 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126159341 | 12615934 | 1 | PS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, BID | U | 1402630BB | 202192 | 5 | MG | TABLET | |||||
| 126159341 | 12615934 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | 5 MG, BID | U | 1403284AA | 202192 | 5 | MG | TABLET | ||||||
| 126159341 | 12615934 | 3 | SS | CALCITRIOL. | CALCITRIOL | 1 | UNK | 0 | |||||||||||
| 126159341 | 12615934 | 4 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 0 | ||||||||||||
| 126159341 | 12615934 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 126159341 | 12615934 | 6 | C | BUDESONIDE. | BUDESONIDE | 1 | 0 | ||||||||||||
| 126159341 | 12615934 | 7 | C | MIDODRINE | MIDODRINE | 1 | 0 | ||||||||||||
| 126159341 | 12615934 | 8 | C | ULORIC | FEBUXOSTAT | 1 | 0 | ||||||||||||
| 126159341 | 12615934 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 126159341 | 12615934 | 10 | C | LIALDA | MESALAMINE | 1 | 0 | ||||||||||||
| 126159341 | 12615934 | 11 | C | METOLAZONE. | METOLAZONE | 1 | 0 | ||||||||||||
| 126159341 | 12615934 | 12 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126159341 | 12615934 | 1 | Myelofibrosis |
| 126159341 | 12615934 | 3 | Product used for unknown indication |
| 126159341 | 12615934 | 4 | Product used for unknown indication |
| 126159341 | 12615934 | 5 | Product used for unknown indication |
| 126159341 | 12615934 | 6 | Product used for unknown indication |
| 126159341 | 12615934 | 7 | Product used for unknown indication |
| 126159341 | 12615934 | 8 | Product used for unknown indication |
| 126159341 | 12615934 | 9 | Product used for unknown indication |
| 126159341 | 12615934 | 10 | Product used for unknown indication |
| 126159341 | 12615934 | 11 | Product used for unknown indication |
| 126159341 | 12615934 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126159341 | 12615934 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126159341 | 12615934 | Abdominal discomfort | |
| 126159341 | 12615934 | Blood glucose increased | |
| 126159341 | 12615934 | Diarrhoea | |
| 126159341 | 12615934 | Hypotension | |
| 126159341 | 12615934 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126159341 | 12615934 | 1 | 20150924 | 0 | ||
| 126159341 | 12615934 | 2 | 20150924 | 0 | ||
| 126159341 | 12615934 | 3 | 201607 | 0 |